Shanghai Qilu Pharmaceutical Research Center

Shanghai Qilu Pharmaceutical Research Center serves as the primary innovation and drug discovery hub for the Qilu Pharmaceutical Group. Located in the Zhangjiang Hi-Tech Park, the center focuses on the development of novel biologics and small molecule therapeutics, particularly in the fields of oncology, infectious diseases, and metabolic disorders. The facility utilizes advanced technology platforms, including the proprietary Mabpair platform for bispecific antibody synthesis, to drive its extensive pipeline. By integrating global R&D resources, the center facilitates the transition of Qilu Pharmaceutical from a generics-focused manufacturer to an innovation-led global pharmaceutical player. Its research efforts have led to several high-profile candidates currently in late-stage clinical trials and regulatory review.